0 XP 0   0   0  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Corvus Pharmaceuticals Inc - Trending symbols

Latest News of Corvus Pharmaceuticals Inc

DateTitleRead
2025-08-01
15:00
BioMarin Announces Appointment of Ian T. Clark to Board of DirectorsRead



Trends

 2024-03-312024-06-302024-09-302024-12-312025-03-31
Income before Tax -5,7011,439-4,262-35,955-40,21728,104-12,11327,30615,193
Net Income -5,7011,439-4,262-35,955-40,21728,104-12,11327,30615,193
Net Income from Continuing Operations -5,7011,439-4,262-35,955-40,21728,104-12,11327,30615,193
Net Working Capital 25,795-4,70821,087-4,95616,13118,79234,923-38,408-3,485
Total Other Income Expense Net -1,29915-1,284419-865-137-1,0021,554552
Other Current Liabilities 5,9863856,3712,1998,570-1,0227,548-8,811-1,263
Depreciation and Amortization 93-687592294-116-22
Net Interest Income 8611,4222,283-1012,182-1,642540-555-15
Accumulated Other Comprehensive Income 1,3754941,8691181,987-1,648339-1,532-1,193

Comments

How you think about this?

Leave a comment

Stay informed about Corvus Pharmaceuticals Inc.

Receive notifications about Corvus Pharmaceuticals Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.